While the HHS public health emergency is ending, COVID-19 remains a high priority and the U.S. Food and Drug Administration will remain engaged with numerous activities to protect and promote public health.
Lessons from COVID-19 must be learned before the next outbreak
First lessons from government evaluations of COVID-19 responses: A synthesis
US FDA Emails, Sales & Deals - Page 16
Advance care planning in the community in the context of COVID-19 - The Centre for Evidence-Based Medicine
Is America Prepared for the Pandemic After COVID-19? - The Atlantic
Adapting Delivery Response COVID-19: International Lessons for US
Pandemic Preparedness - PAHO/WHO Pan American Health Organization
Coronavirus Emergency Management Best Practices
Lessons from the frontline: The COVID-19 pandemic emergency care experience from a human resource perspective in the Pacific region - ScienceDirect
MCMi News Archive
Science and Engineering Laboratories: Updates from FDA/CDRH - US FDA